| BRGAX | VFFSX | BRGAX / VFFSX | |
| Total Expense Ratio | 0.36 | 0.01 | 3,600% |
| Annual Report Gross Expense Ratio | 0.36 | 0.01 | 3,600% |
| Fund Existence | 15 years | 10 years | - |
| Gain YTD | 11.217 | 11.121 | 101% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 5000000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.16B | 1.76T | 0% |
| Annual Yield % from dividends | 0.77 | 1.05 | 73% |
| Returns for 1 year | 14.13 | 15.26 | 93% |
| Returns for 3 years | 70.41 | 70.33 | 100% |
| Returns for 5 years | 69.12 | 70.49 | 98% |
| Returns for 10 years | 266.62 | 258.63 | 103% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TXBC | 17.29 | 0.41 | +2.40% |
| 21Shares FTSE Crypto 10 ex-BTC Index ETF | |||
| FSMD | 50.80 | 0.39 | +0.77% |
| Fidelity Small-Mid Multifactor ETF | |||
| MAYZ | 36.66 | 0.27 | +0.73% |
| TrueShares Structured Outcome May ETF | |||
| BBP | 103.46 | -0.01 | -0.01% |
| Virtus LifeSci Biotech Products ETF | |||
| ISD | 12.11 | -0.05 | -0.41% |
| PGIM High Yield | |||